HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data

Joint Bone Spine

Volumn 80, Issue 5, 2013, Pages 488-491

  Kim, Tae Jong ^a   Sung, Il Hoon ^b   Lee, Seunghun ^b   Joo, Kyung Bin ^b   Choi, Jung Hyun ^c   Park, Dong Jin ^a   Park, Yong Wook ^a   Lee, Shin Seok ^a   Kim, Tae Hwan ^b  

^a Chonnam National University Medical School   (South Korea)

^b Hanyang University   (South Korea)

^c Hankuk University of Foreign Studies   (South Korea)

Author keywords

Ankylosing spondylitis; HLA B27; Homozygosity; MSASSS

Indexed keywords

HLA B27 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CERVICAL SPINE; DISEASE COURSE; DISEASE DURATION; FEMALE; HOMOZYGOSITY; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RADIOLOGIST; REGISTER; SCORING SYSTEM; SOUTH KOREA; SPINE RADIOGRAPHY; SPONDYLOARTHROPATHY;

ANKYLOSING SPONDYLITIS; HLA-B27; HOMOZYGOSITY; MSASSS;

ADULT; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HETEROZYGOTE; HLA-B27 ANTIGEN; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SPONDYLITIS, ANKYLOSING;

EID: 84885907968     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.12.003     Document Type: Article

References (21)

1. Brown M.A., Kennedy L.G., MacGregor A.J., et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997, 40:1823-1828.
2. Hamersma J., Cardon L.R., Bradbury L., et al. Is disease severity in ankylosing spondylitis genetically determined?. Arthritis Rheum 2001, 44:1396-1400.
3. Brewerton D.A., Hart F.D., Nicholls A., et al. Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
4. Suarez-Almazor M.E., Russell A.S. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987, 14:302-304.
5. Khan M.A., Kushner I., Braun W.E., et al. HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 1978, 11:434-438.
6. Cohen T. Are homozygous for HLA-B27 more susceptible to ankylosing spondylitis (Letter). N Engl J Med 1976, 295:342.
7. Arnett F.C., Schacter B.Z., Hochberg M.C., et al. Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families. Arthritis Rheum 1977, 20:797-804.
8. Spencer D.G., Hick H.M., Dick W.C. Ankylosing spondylitis-the role of HLA-B27 homozygosity. Tissue Antigens 1979, 14:379-384.
9. Moller P., Berg K. Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics. Clin Genet 1983, 24:73-89.
10. Jaakkola E., Herzberg I., Laiho K., et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006, 65:775-780.
11. Kim T.J., Na K.S., Lee H.J., et al. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 2009, 27:574-579.
12. Kim T.J., Kim T.H. Clinical spectrum of ankylosing spondylitis in Korea. Joint Bone Spine 2010, 77:235-240.
13. Kvien T.K., Moller P., Dale K. Juvenile ankylosing spondylitis and HLA-B27 homozygosity. Scand J Rheumatol 1985, 14:47-50.
14. Wanders A., Heijde D., Landewe R., et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005, 52:1756-1765.
15. Dougados M., Simon P., Braun J., et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 2011, 70:249-251.
16. Haroon N., Maksymowych W.P., Rahman P., et al. Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort. Arthritis Rheum 2012, 64:1119-1126.
17. Ward M.M., Hendrey M.R., Malley J.D., et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 2009, 61:859-866.
18. Gonzalez-Roces S., Alvarez M.V., Gonzalez S., et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997, 49:116-123.
19. D'Amato M., Fiorillo M.T., Carcassi C., et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995, 25:3199-3201.
20. Hwang M.W., Cho Y.J. HLA-B27 subtypes in Korean patients with ankylosing spondylitis. Korean J Clin Pathol 1999, 19:92-97.
21. Lee S.H., Choi I.A., Lee Y.A., et al. Human leukocyte antigen-B*2705 is the predominant subtype in the Korean population with ankylosing spondylitis, unlike in other Asians. Rheumatol Int 2008, 29:43-46.